Abstract
Reversible cerebral vasoconstriction syndrome (RCVS) is a group of disorders characterized by segmental narrowing and dilatation of medium-to-large cerebral arteries, clinically presenting with recurrent episodes of sudden-onset thunderclap headaches, with or without focal neurological deficits. Cerebral vasoconstriction is typically reversible, with spontaneous resolution within 3 months. Although the syndrome has generally a benign course, patients with neurological deficits may experience worse outcome. The main imaging finding is segmental constriction of intracranial arteries, which can be associated with subarachnoid hemorrhage and/or ischemic foci. Other possible findings are intracranial hemorrhage, subdural bleeding and cerebral edema. The latter may have a pattern which can resemble that of posterior reversible encephalopathy syndrome, a condition that can overlap with RCVS. New imaging techniques, such as vessel wall imaging and arterial spin labeling, are proving useful in RCVS and are giving new insights into the pathophysiology of this condition. In this paper, we aim to review neuroimaging findings of RCVS.
Similar content being viewed by others
Introduction
Reversible cerebral vasoconstriction syndrome (RCVS) is a cerebrovascular disease characterized by diffuse, multifocal and segmental arterial constriction resolving within 3 months, clinically presenting with recurrent episodes of sudden-onset thunderclap headaches, with or without other neurological deficits [1]. The syndrome affects most commonly women aged between 20 and 50 years [2]. The exact incidence is still unknown, probably because RCVS is likely to be underdiagnosed. Ducros et al. reported that RCVS was the final diagnosis in approximately 0.26% of patients presenting to the emergency department due to headache [3].
It can occur spontaneously or can be caused by triggers. Puerperium and vasoactive medications (for instance, bromocriptine, ergotamine, pseudoephedrine, selective serotonin-uptake inhibitors and interferon) account for almost half of the cases [4]. Other known triggers are alcohol, drugs (such as amphetamines, cannabis, cocaine, ecstasy and nicotine), blood products, migraines, tumors (in particular, Pheochromocytoma and Paraganglioma), antiphospholipid antibody syndrome and thrombotic thrombocytopenic purpura [5].
RCVS has also been described in the context of SARS-Cov-2 infection [6]. Although this association needs further validation, SARS-CoV-2 may trigger RCVS because of the direct interaction of the virus with endothelial cells and Angiotensin-converting enzyme type 2 receptors, with subsequent possible alterations of vessels caliber [7].
Pathogenesis is still unknown, although transient deregulation in cerebral vascular tone is thought to be a key feature, whereas active inflammation has not been shown on brain biopsy in these patients [4]. Sympathetic overactivity, oxidative stress and endothelial disfunction are probably the main factors involved in the pathogenesis of RCVS, although the specific contribution of each one probably varies depending on the specific trigger. For instance, in case of vasoactive medications and Pheochromocytoma, sympathetic overactivity is thought to play a crucial role [8]. Oxidative stress is probably involved in RCVS, as markers of this process have been reported to be elevated in the syndrome [9].
RCVS frequently overlaps with posterior reversible encephalopathy syndrome (PRES), which clinically presents with headache, visual alterations and seizure [10]. On imaging, cerebral edema is an important feature of PRES, and it usually involves the occipital lobes, with cortico-subcortical distribution [11]. Although pathogenesis of PRES is still unknown, endothelial disfunction with subsequent alteration of permeability may be the main pathological mechanism, especially in normotensive patients [12]. RCVS and PRES share clinical, radiological and pathophysiological features, therefore it has been recently proposed that they might represent a disease continuum [11].
Calabrese et al. have proposed diagnostic criteria for RCVS, which have been modified by the International Headache Society [1]. They include both clinical and neuroradiological findings, such as thunderclap headache and the presence of subarachnoid hemorrhage (SAH). Recently, diagnostic scores have been introduced to improve the diagnostic work-up of RCVS. Rocha et al. developed the RCVS2 score, which is based on both clinical and imaging findings. It includes thunderclap headache, female gender, carotid artery involvement, presence of RCVS triggers and SAH [13]. It showed high specificity and sensitivity, mostly for higher score (specificity > 99% and sensibility > 90%, for score higher than 5). The RCVS-TCH score is only based on clinical features, such as thunderclap headache, female sex, presence of triggers and blood pressure surge [14]. It showed high sensitivity and specificity for score higher than 7 (sensitivity of 80% and specificity of 97%).
Clinically, patients with RCVS suffer from multiple episodes of thunderclap headache, recurring over 1–4 weeks in 94–100% of cases [15]. The headaches in RCVS may be the only clinical manifestation, and they are characterized by excruciating pain, with predominant bilateral and occipital distribution, duration around three hours and complete resolution within 2–3 weeks [16]. Focal neurological deficits may occur in 9–63%, and can be transient or permanent [1]. Other possible clinical manifestations are photophobia, phonophobia, nausea, vomiting and encephalopathy [17]. Seizures have been reported in 21% of patients and they can be focal or generalized [15].
RCVS is usually monophasic and self-limiting, with complete resolution of symptoms within 3 months [18]. Unfortunately, complications are reported in RCVS and therefore, neurological sequelae are possible. Hemorrhagic complications are described in up to 34% of cases, usually occur in the first week, and they are more frequent in women with history of migraine [19]. Hemorrhages in RCVS may be the consequence of vessel caliber dysregulation, with post-ischemic reperfusion injury and damage of arterial walls [20]. Another possible early complication is PRES, whereas ischemic events tend to appear during the second week [21]. RCVS may also have a fulminant course in the postpartum, with massive ischemia and brain edema leading to death in 8–24 days after delivery [22].
Early recognition of the syndrome is crucial to manage the symptoms effectively. Firstly, it is necessary to identify and eliminate any trigger. Calcium channel blockers including Nimodipine and Verapamil have been extensively used to relieve headache as a first-line therapy [21]. Intravenous magnesium sulfate may be considered in postpartum RCVS with eclampsia [23]. Retrospective data suggest significant risk of clinical worsening using steroids for treatment of RCVS [24].
Aim of this review is to describe neuroimaging findings of RCVS reported in the scientific literature so far (Table 1).
Computed tomography
Non-contrast computed tomography (CT) is usually the first imaging exam performed in patients with RCVS, as they present at the emergency department because of thunderclap headache. The exam may result negative in more than half of the cases [24]. Therefore, Fukaguchi et al. have proposed to perform clinical and imaging follow-up for at least 2 weeks to exclude the syndrome [25].
Hemorrhagic manifestations have been reported in 34–43% of cases and they may consist of SAH, intracranial hemorrhage and subdural bleeding, with possible overlapping of different types in the same patient [3, 26]. SAH (Fig. 1) is the most frequent hemorrhagic manifestation, representing almost 38% of all hemorrhagic complications in RCVS [26]. It is usually mild and located in the cerebral sulci near the vertex [27]. Topcuoglu et al. evaluated 162 patients with RCVS and the distribution of the blood was bilateral in almost 38% of case [26]. Plus, there was involvement of one cortical sulcus in 36% of cases, two sulci in 26% of cases and more than three sulci in 38% of patients. Blood rarely extended to the Sylvian fissures and ambient cistern [26]. The most frequent location was the frontal lobe (79% of cases), followed by the parietal region (31% of cases), whereas the occipital and temporal lobes were rarely involved (only 23 and 10% of cases, respectively) [26]. In 90% of cases SAH was present in the initial imaging. SAH may also affect cerebellar hemispheres, although this location is rare [27]. In almost half of the cases, SAH is associated with intracerebral hemorrhage and/or ischemic stroke [28, 29].
Topcuoglu et al. also evaluated intracranial hemorrhages (ICH) in RCVS (Fig. 2), reporting them as rare (13%) [26]. They were usually associated with other hemorrhagic manifestations and were single in the majority of cases [30]. The location was mainly lobar, but they could also occur in the deep gray nuclei and cerebellum [26]. They were of small amount (less than 10 mm3) and usually preceded SAH, although they were both early complications, mainly occurring in the first week after clinical onset [26]. ICH in the context of RCVS seems to be more frequent in women, in particular with history of migraine [3].
Subdural hematoma are extremely rare in RCVS (prevalence of nearly 2% of cases) and they are usually acute and associated with other hemorrhagic events [3]. In particular, they appear in areas adjacent to ICH [26].
Wilson et al. have described a case of isolated intraventricular hemorrhage in a clinical setting compatible with RCVS, but further scientific reports are required to validate this finding as associated with the syndrome and not as a concomitant event [31].
Ischemic stroke can also occur in almost 50% of cases of RCVS and it may rarely overlap with cerebral hemorrhage [32].
In the setting of patients with acute severe headache, the American College of Radiology Appropriateness Criteria report unenhanced head CT as the initial imaging test [33]. If SAH is found or neurological examinations suggest a secondary headache, CTA is suggested to provide additional information in the diagnostic work-up and in particular to rule out vascular malformations, cerebral aneurysms, venous sinus thrombosis and RCVS [34].
Magnetic resonance imaging
Magnetic resonance (MR) is frequently performed in the setting of suspected RCVS to detect complications, such as intracerebral bleeding (Fig. 3), and exclude other differential diagnosis. Fluid-attenuated inversion recovery (FLAIR) sequences are useful to detect SAH (Fig. 4) and cerebral edema [35]. Furthermore, hyperintensity of cerebral vessels along the sulci on FLAIR images has been described [36]. It may be caused by vasoconstriction and can be differentiated from SAH using susceptibility weighted sequences.
Diffusion weighted imaging (DWI) may demonstrate the presence of ischemic stroke (Fig. 5) [37]. In RCVS, ischemic lesions are usually bilateral and manifest in arterial watershed distribution, probably due to cerebral vasoconstriction (Fig. 6) [38]. Cerebellar stroke has also been described in RCVS, although it is a rare event [39].
Cerebral edema is a possible complication of RCVS and it has been reported in almost 10% of cases [40]. It usually occurs in the first week after clinical onset, showing complete resolution within 1 month [4]. Ischemic stroke and brain hemorrhages are frequently associated [3]. On FLAIR sequences, it appears as symmetrical areas of hyperintensity, usually in the parieto-occipital regions [10]. This pattern resembles that of PRES, suggesting a common pathophysiological mechanism underlying these two conditions [41].
MR angiography is extremely important to evaluate the presence of segmental vasoconstriction of cerebral arteries in RCVS. It usually affects large-to-medium-sized arteries with an appearance of alternating areas of constriction and dilatation, giving a typical “string of bead” or “sausage on a string”appearance (Fig. 7) [42] The peak of vasoconstriction is around 16 days after clinical onset, and it resolves within 3 months (Fig. 8) [2].
Vessel wall imaging (VWI) is a new MR technique which enables the evaluation of blood vessel wall of proximal intracranial arteries [43]. It requires specific high-resolution and black-blood sequences, high spatial resolution and high-field-strength magnets, as cerebral vessels are only few millimeters thick [44]. In the past few years, VWI has proved to be useful in the setting of RCVS, in particular to differentiate this entity from other forms of arteriopathy [45]. For instance, VWI may be used to differentiate RCVS from vasculitis as in the first case there is thickening of the vessel wall with no or mild enhancement, whereas in vasculitis vessel wall enhancement tends to be prominent and persistent [46]. Chen et al. prospectively evaluated 48 patients with RCVS and 45.8% of them showed vessel wall enhancement on VWI, which was mild in 77.3% of cases and concentric in 72.7% of cases [47]. Interestingly, vessel wall enhancement not always co-localized with vasocontraction [47]. M1 tract of the middle cerebral artery was the most common affected vessel [47]. During follow-up, 35.7% of patients had persistence of vessel wall enhancement, whereas in 64.3% of cases there was complete resolution [47].
Perfusion MR imaging techniques, such as dynamic susceptibility contrast, are not routinely performed in RCVS. Rosenbloom et al. reported a case of RCVS where MR perfusion showed areas of hypoperfusion in watershed territories, which later evolved in ischemic areas [48].
Arterial spin labeling (ASL) is a perfusion MR technique, which enables cerebral blood flow (CBF) evaluation, without the need of Gadolinium injection [49]. Kano et al. performed ASL in five patients with RCVS, and it showed higher sensitivity than MR angiography in detecting hypoperfusion [50]. Vasoconstriction reached its peak in the second week with subsequent gradual normalization [50]. Furthermore, it showed a centripetal progression, beginning from distal arteries and affecting the central vessels later. In the area where PRES and SAH were present, CBF was lower than in other regions of the brain, probably because of breakdown of autoregulation [50].
Digital subtraction angiography
Digital subtraction angiography (DSA) is the gold standard to evaluate cerebral arterial vasoconstriction (Fig. 9) [19]. Typically, it shows bilateral and diffuse areas of segmental narrowing and dilatation of medium-to-large arteries, which determines the typical “string of beads” pattern [51]. The most frequently affected vessels are the basilar artery and the carotid siphon [52, 53]. What is more, vasoconstriction does not constantly affects the same vessel tracts [54]. On repeated DSA, there might be resolution of some constrictions with new areas of narrowing, with centripetal progression during follow-up [52]. Furthermore, the conspicuity of vasoconstriction may fluctuate over time, with some areas showing dilatation and other narrowing [24]. In a minority of cases (prevalence of almost 16%), the pattern of vasoconstriction can be hemispheric or focal [32].
It is important to acknowledge that if DSA is performed within the first week after clinical onset, it may be normal [54]. This probably happens because vasoconstriction begins from small and peripheral vessels, which are not easily evaluated with DSA. In this case, it is suggested to repeat DSA in the second week, as the peak of vasoconstriction is reached at day 16 [55].
Furthermore, DSA can be used to prove reversibility of vasoconstriction after intra-arterial administration of vasodilator, such as Verapamil [56]. This finding is important to demonstrate reversibility of arterial vasoconstriction, which can help early diagnosis of RCVS [57].
Differential diagnosis
There are multiple clinical conditions which overlap with RCVS (Table 2). Firstly, it is important to rule out aneurysmal rupture as it may cause thunderclap headache [58]. Key elements to distinguish these two entities are clinical presentation and the pattern of distribution of SAH. RCVS is characterized by relapsing–remitting episodes of thunderclap headache, which is usually monophasic in case aneurysmal rupture or preceded by sentinel headache [59]. In case of aneurysmal SAH, blood distributes in cerebral cisterns near the ruptured aneurysm, in particular if middle cerebral artery or anterior communicating artery are interested [60]. The pattern of arterial vasoconstriction associated with aneurysmal rupture is not specific and therefore it is not easy to distinguish it from that of RCVS [61].
Nonaneurysmal SAH probably has a venous origin [62]. Blood is usually located in the perimesencephalic region, thus helping in differentiation with RCVS [63].
Primary angiitis of the central nervous system (PACNS) is in another condition to consider among the differential diagnosis of RCVS. PACNS causes a slowly progressive and very intense headache, and it is more frequent in middle-aged men [64]. Furthermore, this condition has dismal prognosis without adequate and rapid immunosuppressive therapy [65]. In PACNS, brain MR shows multiple cerebral infarcts of different ages, and hemorrhagic events are rare [66]. Furthermore, the pattern of vasoconstriction is different from that of RCVS as it is multi-focal and mainly interests mid-to-distal cerebral arteries [67]. Finally, VWI has proved useful to rule out PACNS, as it shows concentric wall thickening and enhancement of the affected vessels [68].
Cortical vein thrombosis should also be considered, as it shares clinic-radiological features with RCVS. In particular, they are both more frequent in pregnant women, usually determine thunderclap headache, may determine SAH at convexity and ischemic stroke [69]. An important clue to make the correct diagnosis is to look for cortical vein hypointensity on susceptibility-weighted sequences [70].
Finally, amyloid angiopathy may also determine cortical SAH, but it is more frequent in the elderly, and it does not cause thunderclap headache. Furthermore, it usually determines ICH and microbleeds with peripheral pattern [71].
Conclusions
RCVS is a not completely understood and under-diagnosed clinical syndrome, characterized by recurrence of thunderclap headache and reversible diffuse areas of narrowing and dilatation, mainly affecting large-to-medium cerebral arteries.
In the scientific literature multiple imaging findings have been reported in RCVS, such as SAH, intracranial hemorrhage, subdural bleeding, ischemic stroke, PRES and segmental vasoconstriction of cerebral arteries with a “string of bead” appearance. Furthermore, advanced imaging techniques, (namely, vessel wall imaging and ASL) could improve diagnostic work-up and possibly give new insights in the pathophysiology of this condition. The neuroradiologist should be aware of these imaging findings as rapid diagnosis is crucial to improve prognosis.
Abbreviations
- RCVS:
-
Reversible cerebral vasoconstriction syndrome
- PRES:
-
Posterior reversible encephalopathy syndrome
- SAH:
-
Subarachnoid hemorrhage
- CT:
-
Computed tomography
- ICH:
-
Intracranial hemorrhage
- MR:
-
Magnetic resonance
- FLAIR:
-
Fluid-attenuated inversion recovery
- DWI:
-
Diffusion weighted imaging
- VWI:
-
Vessel wall imaging
- ASL:
-
Arterial spin labeling
- CBF:
-
Cerebral blood flow
- DSA:
-
Digital subtraction angiography
- PACNS:
-
Primary angiitis of the central nervous system
References
Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB (2007) Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146:34. https://doi.org/10.7326/0003-4819-146-1-200701020-00007
Chen S-P, Fuh J-L, Wang S-J et al (2009) Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol NA-NA. https://doi.org/10.1002/ana.21951
Ducros A, Fiedler U, Porcher R et al (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome. Stroke 41:2505–2511. https://doi.org/10.1161/STROKEAHA.109.572313
Ducros A (2012) Reversible cerebral vasoconstriction syndrome. Lancet Neurol 11:906–917. https://doi.org/10.1016/S1474-4422(12)70135-7
Miller et al. (2015) Reversible cerebral vasoconstriction syndrome, Par.pdf
Dakay et al. (2020) Reversible cerebral vasoconstriction syndrome and .pdf
Vacaras V, Frunze S, Cordos AM (2021) Neurological complications in COVID-19 - a diagnostic challenge. J Med Life 14(2):216–224. https://doi.org/10.25122/jml-2021-0045. (PMID: 34104245; PMCID: PMC8169143)
Chen S-P, Yang AC, Fuh J-L, Wang S-J (2013) Autonomic dysfunction in reversible cerebral vasoconstriction syndromes. J Headache Pain 14:94. https://doi.org/10.1186/1129-2377-14-94
Chen S-P, Chung Y-T, Liu T-Y et al (2013) Oxidative stress and increased formation of vasoconstricting F2-isoprostanes in patients with reversible cerebral vasoconstriction syndrome. Free Radic Biol Med 61:243–248. https://doi.org/10.1016/j.freeradbiomed.2013.04.022
Pilato F, Distefano M, Calandrelli R (2020) Posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome: clinical and radiological considerations. Front Neurol 11:34. https://doi.org/10.3389/fneur.2020.00034
Godi C, Falini A (2018) Posterior Reversible Encephalopathy Syndrome (PRES). In: Barkhof F, Jager R, Thurnher M, Rovira Cañellas A (eds) Clinical Neuroradiology. Springer International Publishing, Cham, pp 1–14
Bartynski WS (2008) Posterior reversible encephalopathy syndrome, Part 1: Fundamental imaging and clinical features. Am J Neuroradiol 29:1036–1042. https://doi.org/10.3174/ajnr.A0928
Rocha EA, Topcuoglu MA, Silva GS, Singhal AB (2019) RCVS2 score and diagnostic approach for reversible cerebral vasoconstriction syndrome. Neurology 92:e639–e647. https://doi.org/10.1212/WNL.0000000000006917
Cho S, Lee MJ, Gil YE, Chung C-S (2021) RCVS–TCH score can predict reversible cerebral vasoconstriction syndrome in patients with thunderclap headache. Sci Rep 11:7750. https://doi.org/10.1038/s41598-021-87412-7
Chen S-P, Fuh J-L, Wang S-J (2010) Reversible cerebral vasoconstriction syndrome: an under-recognized clinical emergency. Ther Adv Neurol Disord 3:161–171. https://doi.org/10.1177/1756285610361795
Ducros A, Wolff V (2016) The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache J Head Face Pain 56:657–673. https://doi.org/10.1111/head.12797
Katz BS, Fugate JE, Ameriso SF et al (2014) Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 71:68. https://doi.org/10.1001/jamaneurol.2013.4639
Robert Th, Kawkabani Marchini A, Oumarou G, Uské A (2013) Reversible cerebral vasoconstriction syndrome identification of prognostic factors. Clin Neurol Neurosurg 115:2351–2357. https://doi.org/10.1016/j.clineuro.2013.08.014
Ducros A, Bousser M-G (2009) Reversible cerebral vasoconstriction syndrome. Pract Neurol 9:256–267. https://doi.org/10.1136/jnnp.2009.187856
Singhal AB (2011) Reversible cerebral vasoconstriction syndrome and hemorrhagic events: Who Precedes Whom?—Reply. Arch Neurol 68:1614. https://doi.org/10.1001/archneur.68.12.1615-a
Ducros A, Boukobza M, Porcher R et al (2007) The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain J Neurol 130:3091–3101. https://doi.org/10.1093/brain/awm256
Fugate JE, Wijdicks EFM, Parisi JE et al (2012) Fulminant postpartum cerebral vasoconstriction syndrome. Arch Neurol 69:111–117. https://doi.org/10.1001/archneurol.2011.811
Mijalski C, Dakay K, Miller-Patterson C et al (2016) Magnesium for treatment of reversible cerebral vasoconstriction syndrome: case series. Neurohospitalist 6:111–113. https://doi.org/10.1177/1941874415613834
Singhal AB, Hajj-Ali RA, Topcuoglu MA et al (2011) Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 68:1005–1012. https://doi.org/10.1001/archneurol.2011.68
Fukaguchi K, Goto T, Fukui H et al (2020) Reversible cerebral vasoconstriction syndrome: the importance of follow-up imaging within 2 weeks. Acute Med Surg 7:e559. https://doi.org/10.1002/ams2.559
Topcuoglu MA, Singhal AB (2016) Hemorrhagic reversible cerebral vasoconstriction syndrome: features and mechanisms. Stroke 47:1742–1747. https://doi.org/10.1161/STROKEAHA.116.013136
Miller TR, Shivashankar R, Mossa-Basha M, Gandhi D (2015) Reversible cerebral vasoconstriction syndrome, Part 2: Diagnostic work-up, imaging evaluation, and differential diagnosis. Am J Neuroradiol 36:1580–1588. https://doi.org/10.3174/ajnr.A4215
Santos E, Zhang Y, Wilkins A et al (2009) Reversible cerebral vasoconstriction syndrome presenting with haemorrhage. J Neurol Sci 276:189–192. https://doi.org/10.1016/j.jns.2008.08.034
Wong SH, Dougan C, Chatterjee K et al (2009) Recurrent thunderclap headaches and multilobar intracerebral haemorrhages: two cases of reversible cerebral vasoconstriction syndrome (RCVS). Cephalalgia Int J Headache 29:791–795. https://doi.org/10.1111/j.1468-2982.2008.01805.x
Garg A, Rocha M, Starr M, Ortega-Gutierrez S (2021) Predictors and outcomes of hemorrhagic stroke in reversible cerebral vasoconstriction syndrome. J Neurol Sci 421:117312. https://doi.org/10.1016/j.jns.2021.117312
Wilson D, Marshall CR, Solbach T et al (2014) Intraventricular hemorrhage in reversible cerebral vasoconstriction syndrome. J Neurol 261:2221–2224. https://doi.org/10.1007/s00415-014-7499-0
Song T-J, Lee KH, Li H et al (2021) Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci 25:3519–3529. https://doi.org/10.26355/eurrev_202105_25834
Whitehead MT, Cardenas AM, Corey AS et al (2019) ACR Appropriateness Criteria® headache. J Am Coll Radiol 16:S364–S377. https://doi.org/10.1016/j.jacr.2019.05.030
Salmela MB, Mortazavi S, Jagadeesan BD et al (2017) ACR Appropriateness Criteria ® cerebrovascular disease. J Am Coll Radiol 14:S34–S61. https://doi.org/10.1016/j.jacr.2017.01.051
Ashraf R, Akhtar M, Akhtar S, Manzoor I (2019) Diagnostic accuracy of flair in detection of acute subarachnoid hemorrhage in patients presenting with severe headache. J Neuroradiol J Neuroradiol 46:294–298. https://doi.org/10.1016/j.neurad.2018.07.001
Chen S-P, Fuh J-L, Lirng J-F, Wang S-J (2012) Hyperintense vessels on flair imaging in reversible cerebral vasoconstriction syndrome. Cephalalgia 32:271–278. https://doi.org/10.1177/0333102412437387
Freilinger T, Schmidt C, Duering M et al (2010) Reversible cerebral vasoconstriction syndrome associated with hormone therapy for intrauterine insemination. Cephalalgia Int J Headache 30:1127–1132. https://doi.org/10.1177/0333102409360675
Burton TM, Bushnell CD (2019) Reversible cerebral vasoconstriction syndrome. Stroke 50:2253–2258. https://doi.org/10.1161/STROKEAHA.119.024416
Imai N, Yagi N, Konishi T et al (2010) Ischemic stroke associated with cough and cold preparation containing methylephedrine and supplement containing Chinese herbal drugs. Intern Med Tokyo Jpn 49:335–338. https://doi.org/10.2169/internalmedicine.49.2704
Santos L, Azevedo E (2016) Reversible cerebral vasoconstriction syndrome—a narrative revision of the literature. Porto Biomed J 1:65–71. https://doi.org/10.1016/j.pbj.2016.04.002
Ollivier M, Bertrand A, Clarençon F et al (2017) Neuroimaging features in posterior reversible encephalopathy syndrome: a pictorial review. J Neurol Sci 373:188–200. https://doi.org/10.1016/j.jns.2016.12.007
Ueki H, Sanayama Y, Miyajima A et al (2016) Reversible cerebral vasoconstriction syndrome promptly diagnosed with magnetic resonance imaging including magnetic resonance angiography during immunosuppressive therapy in a 16-year-old girl with refractory cytopenia of childhood. Hematol Rep 8. https://doi.org/10.4081/hr.2016.6673
Mandell DM, Mossa-Basha M, Qiao Y et al (2017) Intracranial vessel wall MRI: principles and expert consensus recommendations of the American Society of Neuroradiology. Am J Neuroradiol 38:218–229. https://doi.org/10.3174/ajnr.A4893
Lindenholz A, van der Kolk AG, Zwanenburg JJM, Hendrikse J (2018) The use and pitfalls of intracranial vessel wall imaging: how we do it. Radiology 286:12–28. https://doi.org/10.1148/radiol.2017162096
Edjlali M, Qiao Y, Boulouis G, et al (2020) Vessel wall MR imaging for the detection of intracranial inflammatory vasculopathies. Cardiovasc Diagn Ther 10:1108–1119. https://doi.org/10.21037/cdt-20-324
Pensato U, Cevoli S, Cirillo L (2020) Vessel wall imaging in thunderclap headache: a Reversible Cerebral Vasoconstriction Syndrome (RCVS) case. Headache J Head Face Pain 60:2633–2635. https://doi.org/10.1111/head.13992
Chen C-Y, Chen S-P, Fuh J-L et al (2018) Vascular wall imaging in reversible cerebral vasoconstriction syndrome—a 3-T contrast-enhanced MRI study. J Headache Pain 19:74. https://doi.org/10.1186/s10194-018-0906-7
Rosenbloom MH, Singhal AB (2007) CT angiography and diffusion-perfusion MR imaging in a patient with ipsilateral reversible cerebral vasoconstriction after carotid endarterectomy. AJNR Am J Neuroradiol 28:920–922
Grade M, Hernandez Tamames JA, Pizzini FB et al (2015) A neuroradiologist’s guide to arterial spin labeling MRI in clinical practice. Neuroradiology 57:1181–1202. https://doi.org/10.1007/s00234-015-1571-z
Kano Y, Inui S, Uchida Y et al (2021) Quantitative arterial spin labeling magnetic resonance imaging analysis of reversible cerebral vasoconstriction syndrome: a case series. Headache J Head Face Pain 61:687–693. https://doi.org/10.1111/head.14094
Slivka A, Philbrook B (1995) Clinical and angiographic features of thunderclap headache. Headache 35:1–6. https://doi.org/10.1111/j.1526-4610.1995.hed3501001.x
Call GK, Fleming MC, Sealfon S et al (1988) Reversible cerebral segmental vasoconstriction. Stroke 19:1159–1170. https://doi.org/10.1161/01.str.19.9.1159
Melki E, Denier C, Théaudin-Saliou M et al (2012) External carotid artery branches involvement in reversible cerebral vasoconstriction syndrome. J Neurol Sci 313:46–47. https://doi.org/10.1016/j.jns.2011.09.033
Noskin O, Jafarimojarrad E, Libman RB, Nelson JL (2006) Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants. Neurology 67:159–160. https://doi.org/10.1212/01.wnl.0000223648.76430.27
Calabrese LH, Gragg LA, Furlan AJ (1993) Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol 20:2046–2050
Ospel JM, Wright CH, Jung R et al (2020) Intra-arterial verapamil treatment in oral therapy–refractory reversible cerebral vasoconstriction syndrome. Am J Neuroradiol 41:293–299. https://doi.org/10.3174/ajnr.A6378
Linn J, Fesl G, Ottomeyer C et al (2011) Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia Int J Headache 31:1074–1081. https://doi.org/10.1177/0333102410394673
de Oliveira Manoel AL, Mansur A, Murphy A et al (2014) Aneurysmal subarachnoid haemorrhage from a neuroimaging perspective. Crit Care 18:557. https://doi.org/10.1186/s13054-014-0557-2
Valença MM, Andrade-Valença LPA, Bordini CA, Speciali JG (2008) Thunderclap headache attributed to reversible cerebral vasoconstriction: view and review. J Headache Pain 9:277–288. https://doi.org/10.1007/s10194-008-0054-6
Karttunen AI, Jartti PH, Ukkola VA et al (2003) Value of the quantity and distribution of subarachnoid haemorrhage on CT in the localization of a ruptured cerebral aneurysm. Acta Neurochir (Wien) 145:655–661. https://doi.org/10.1007/s00701-003-0080-8
Ansari SA, Rath TJ, Gandhi D (2011) Reversible cerebral vasoconstriction syndromes presenting with subarachnoid hemorrhage: a case series. J NeuroInterventional Surg 3:272–278. https://doi.org/10.1136/jnis.2010.004242
Rouchaud A, Lehman VT, Murad MH et al (2016) Nonaneurysmal perimesencephalic hemorrhage is associated with deep cerebral venous drainage anomalies: a systematic literature review and meta-analysis. Am J Neuroradiol 37:1657–1663. https://doi.org/10.3174/ajnr.A4806
Flaherty ML, Haverbusch M, Kissela B et al (2005) Perimesencephalic subarachnoid hemorrhage: incidence, risk factors, and outcome. J Stroke Cerebrovasc Dis 14:267–271. https://doi.org/10.1016/j.jstrokecerebrovasdis.2005.07.004
Hajj-Ali RA, Singhal AB, Benseler S et al (2011) Primary angiitis of the CNS. Lancet Neurol 10:561–572. https://doi.org/10.1016/S1474-4422(11)70081-3
Birnbaum J, Hellmann DB (2009) Primary angiitis of the central nervous system. ARCH NEUROL 66:6
Abdel Razek AAK, Alvarez H, Bagg S et al (2014) Imaging spectrum of CNS Vasculitis. Radiographics 34:873–894. https://doi.org/10.1148/rg.344135028
Obusez EC, Hui F, Hajj-ali RA et al (2014) High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. Am J Neuroradiol 35:1527–1532. https://doi.org/10.3174/ajnr.A3909
Sundaram S, Pn K, Sharma D et al (2021) High-resolution vessel wall imaging in primary angiitis of central nervous system. Ann Indian Acad Neurol. https://doi.org/10.4103/aian.AIAN_106_21
Canedo-Antelo M, Baleato-González S, Mosqueira AJ et al (2019) Radiologic clues to cerebral venous thrombosis. Radiographics 39:1611–1628. https://doi.org/10.1148/rg.2019190015
Boukobza M, Crassard I, Bousser MG, Chabriat H (2009) MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up. Am J Neuroradiol 30:344–348. https://doi.org/10.3174/ajnr.A1332
Puy L, Pasi M, Rodrigues M et al (2021) Cerebral microbleeds: from depiction to interpretation. J Neurol Neurosurg Psychiatry 92:598–607. https://doi.org/10.1136/jnnp-2020-323951
Funding
No funding was received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical standards
This article does not contain any studies involving human participants performed by any of the authors and informed consent was not requested.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Perillo, T., Paolella, C., Perrotta, G. et al. Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol med 127, 981–990 (2022). https://doi.org/10.1007/s11547-022-01532-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-022-01532-2